Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04885296 · ClinicalTrials.gov registry record · NA

Evaluation of Prototype Lenses With Experimental UV/HEV Blocker

A NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
228
Enrollment target
12
Study locations

NCT04885296 is a NA study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 228 participants, above the 129-participant average among 20 other Visual Acuity trials with a reported enrollment target (77% higher). The trial reports 12 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04885296, a NA study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
228 participants
Enrollment target
12
Study locations

Study Summary

This is a bilateral, 2-week dispensing, randomized, controlled, subject-masked, 2×2 crossover study to evaluate the clinical performance of prototype contact lenses with experimental UV/HEV-blocker.

Conditions Studied

Interventions

  • DEVICE TRP-200
  • DEVICE JJVC Marketed Contact Lens

Study Locations (12)

Florida

  • Dr. James Weber & Associates, PA - Jacksonville
  • Flora Chen Poveda, OD, PA - Orange Park
  • Tallahassee Eye Center - Tallahassee

Texas

  • Gulf Coast Vision Center, Inc. - Houston
  • Frazier Vision, Inc. - Tyler

Georgia

  • Visual Eyes - Roswell

Michigan

  • Birmingham Vision Care - Bloomfield Township

Minnesota

  • Complete Eye Care of Medina - Medina

New Jersey

  • Dr. Debbie H. Kim, OD - Closter

Ohio

  • Professional Vision Care, Inc. - Westerville

Tennessee

  • Optometry Group, LLC - Memphis

Trial Details

FieldValue
Enrollment Target 228 participants
Start Date 2021-05-10
Est. Completion 2021-08-09
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT04885296

The ClinicalTrials.gov registry entry for NCT04885296 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 228 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 129-participant average among 20 other Visual Acuity trials with a reported enrollment target (77% higher). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 2 interventions - of which TRP-200 is the first listed.

NCT04885296 reports 12 study locations spanning 9 distinct geographic areas - top geographies include Florida, Texas, Georgia.

Frequently Asked Questions

What is clinical trial NCT04885296 about?

NCT04885296 is a clinical study titled "Evaluation of Prototype Lenses With Experimental UV/HEV Blocker". This is a bilateral, 2-week dispensing, randomized, controlled, subject-masked, 2×2 crossover study to evaluate the clinical performance of prototype contact lenses with experimental UV/HEV-blocker.

What is the current status of trial NCT04885296?

This trial is currently completed. It is a NA study. The enrollment target is 228 participants. The study started on 2021-05-10. Estimated completion is 2021-08-09.

What conditions does trial NCT04885296 study?

This clinical trial studies the following conditions: Visual Acuity.

What interventions are being tested in trial NCT04885296?

The interventions under investigation include: TRP-200 (DEVICE), JJVC Marketed Contact Lens (DEVICE).

Who is sponsoring clinical trial NCT04885296?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04885296 being conducted?

This trial has 12 study locations across Florida, Georgia, Michigan, Minnesota, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Visual Acuity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.